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The  use  of  cardiac  implantable  electronic  devices  (CIEDs),  which  includes  permanent 
pacemakers and implantable cardioverter-defibrillators, has greatly increased over the past two 
decades. Unfortunately, along with the rising use of cardiac medical devices, there has been a 
disproportional increase in the number of infections of such devices [1]. The rates of infection 
of CIED range from 0.1% to 4%, with an average rate of 1% [2-4]. A recent analysis showed 
that infection rate grew from 1.61% in 1993 to 2.41% in 2008, possibly due to two factors: 
aging of population and increased use of more complex devices [5]. The most important risk 
factors for infection are re-intervention for hematoma evacuation or lead displacement, device 
replacement increasing with aging of population, and use of dual and triple chamber devices 
that  increased  in  the  last  years.                                               
Staphylococcus  epidermidis and  Staphylococcus  aureus,  account  for  70-90% of  all  CIED 
infections,  and have been studied extensively  [6,7].  Non-staphylococcal  organisms,  which 
cause 10 -  30% of  all  CIED infections,  are  so diverse that  they have been  studied  only 
infrequently [8]. The microbiological diversity of non-staphylococcal infections of CIED is 
rather  extensive,  including  other  Gram-positive  bacteria,  Gram-negative  bacteria,  atypical 
bacteria like Nocardia species, fungi like Candida and Aspergillus species, and mycobacterial 
organisms.
The majority of CIED infections reportedly occur within 3 months  after CIED insertion [6].  
Reasons  for  the  higher  rate  of  infection  during  the  early  period  after  CIED implantation 
include procedural contamination and the lack of formation of fibrocollagenous tissue around 
the  leads  until  a  few  months  after  placement,  thereby  making  them  more  prone  to 
microbiological seeding. In contrast, non-staphylococcal infection occurs rather late, usually 
2-3  years  after  implantation.  Compared  to  staphylococci,  non-staphylococcal  organisms 
appear to be less virulent and result in more protracted clinical course. They are generally less 
lethal  with  a  low infection-related  mortality  of  4% compared  with  9% for  S.  aureus  [9].
The probability of CIED infection due to secondary seeding of the cardiac device in patients 
with  Staphylococcus bacteremia is approximately 40% [10]. Previously, non-staphylococcal 
bacteremia was thought not to cause secondary seeding of the device. But subsequent studies 
[8] showed that this was indeed a misconception. Therefore, regardless of the nature of the 
microorganism, one must always remain cautious of the potential for secondary seeding of the 
CIED in any patient with bacteremia or a distant bodily site infection.                       
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A few cases of CIED infections associated with mycobacterial species like  Mycobacterium 
fortuitum,  and  Mycobacterium  avium  complex have  been  reported  in  literature.  CIED 
infections with M. tuberculosis are very rare. In this issue of journal, Kumar A et al report 3 
cases of CIED infection due to M. tuberculosis [11]. M. tuberculosis infection of CIED pocket 
generally follows an indolent course and is devoid of constitutional symptoms. Diagnosis is 
often missed or delayed since routine investigations may not help in identifying the organism 
or the diagnosis is considered only late in the course of the illness. It is important for clinicians 
to consider tuberculosis as an etiology of any CIED infection. It is interesting to note that two 
out of three cases reported were managed conservatively with antituberculous drugs and did 
not  require  device  explantation.                                            
In  patients  with  suspected  CIED  infection,  adequate  Gram-positive  and  Gram-negative 
antibacterial  coverage should be administered  until  microbiological  data  become available. 
When  Gram stain  and routine  cultures  are  not  contributory,  one  should  consider  unusual 
organisms  like  nocardia,  fungi  or  mycobacterium  species.  Considering  these  atypical 
organisms for CIED infection is especially relevant in a patient who is immunocompromised 
or  has  diabetes  mellitus.                                                     
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